These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3389610)

  • 21. [Complications following preventive treatment of thromboembolism with Dihydergot-heparin].
    Andersen KH; Jeppesen IS
    Ugeskr Laeger; 1989 Aug; 151(33):2072-5. PubMed ID: 2672498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ergotism of the lower extremities resulting from thrombosis prevention using DHE-heparin. An angiographic follow-up study].
    Warmuth-Metz M
    Radiologe; 1988 Oct; 28(10):491-3. PubMed ID: 3186973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ergotism precipitated by erythromycin: a rare case of vasospasm.
    Karam B; Farah E; Ashoush R; Jebara V; Ghayad E
    Eur J Vasc Endovasc Surg; 2000 Jan; 19(1):96-8. PubMed ID: 10706847
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ergotism--a risk in the prevention of thrombosis?].
    Jahn R
    Zentralbl Chir; 1985; 110(8):482-5. PubMed ID: 4002912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A minor case of ergotism appearing to be connected with a potentialisation of ergotamine tartrate by erythromycine ethyl-succinate (author's transl)].
    Lagier G; Castot A; Riboulet G; Boesh C
    Therapie; 1979; 34(4):515-21. PubMed ID: 531783
    [No Abstract]   [Full Text] [Related]  

  • 26. What is known about the action of dihydroergotamine on the vasculature in man?
    Müller-Schweinitzer E
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):677-82. PubMed ID: 6396240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. St. Anthony's fire: successful reversal of ergotamine-induced peripheral vasospasm by hydrostatic dilatation.
    Baader W; Herman C; Johansen K
    Ann Vasc Surg; 1990 Nov; 4(6):597-9. PubMed ID: 2261328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Ashenburg RJ
    J Bone Joint Surg Am; 1990 Jan; 72(1):153. PubMed ID: 2295668
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute ischemia of the extremities in the puerperal period].
    Petr P; Jelínek P; Vambera M; Bouzek J; Kresnicka J
    Cas Lek Cesk; 1990 Jan; 129(2):56-7. PubMed ID: 2334952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Iatrogenic ergotism. Responsibility of an ergotamine tartrate-erythromycine propionate association (author's transl)].
    Collet AM; Moncharmont D; San Marco JL; Eissinger F; Pinot JJ; Laselve L
    Sem Hop; 1982 Jul; 58(26-27):1624-6. PubMed ID: 6287638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Iatrogenic ergotism].
    Zicot M
    Rev Med Liege; 1977 Jan; 32(2):43-7. PubMed ID: 841212
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ergotism--a serious complication in the chemical prevention of thromboembolism with heparin-DHE].
    van den Berg E; Walterbusch G; Gotzen L; Rumpf KD; Otten B; Fröhlich H
    Vasa; 1983; 12(1):64-7. PubMed ID: 6837130
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ergotismus as a consequence of migraine prevention].
    Beck B; Daniel H
    Rofo; 1987 Apr; 146(4):470-3. PubMed ID: 3033778
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diffuse cerebral angiopathy with ergotism and persistent neurological disorders].
    Zumstein V; Uske A; Regli F
    Schweiz Rundsch Med Prax; 1987 Nov; 76(47):1315-7. PubMed ID: 3423549
    [No Abstract]   [Full Text] [Related]  

  • 35. [Venous tonus-modifying effect, pharmacokinetics and undesired effects of dihydroergotamine].
    Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):417-28. PubMed ID: 6390997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reactions and interactions of drugs].
    D'Arcy PF
    J Pharm Belg; 1989; 44(2):167-70. PubMed ID: 2778623
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe iatrogenic ergotism: incidence and clinical importance.
    Bongard O; Bounameaux H
    Vasa; 1991; 20(2):153-6. PubMed ID: 1908611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ergotism and heparin-dihydroergotamine prophylaxis.
    Krupp P; Majer M
    Lancet; 1982 Jun; 1(8284):1302. PubMed ID: 6123037
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.
    Bounameaux H; Schneider PA; Mossaz A; Suter P; Vasey H
    Vasa; 1987; 16(4):370-2. PubMed ID: 3424957
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tongue necrosis disclosing Horton's disease. Role of an associated ergotism].
    Saveuse H; Rouveix E; Franc B; Foubert A; Lesur G; Dorra M
    Ann Med Interne (Paris); 1990; 141(7):635-7. PubMed ID: 2085250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.